title: Why not use a high-sensitivity troponin assay as an end point in clinical trials?
authors: Hospital Israelita Albert Einstein, São Paulo, Brazil; Federal University of São Paulo, Brazil.
authors: Carlos Eduardo
authors: CE
authors: dos Santos Ferreira
authors: Federal University of São Paulo, Brazil; University of Santo Amaro, São Paulo, Brazil.
authors: Carolina Nunes
authors: CN
authors: França
authors: Federal University of São Paulo, Brazil.
authors: Francisco Antonio
authors: FA
authors: Helfenstein Fonseca
mesh_terms: D054058:Acute Coronary Syndrome / Q000097:blood* / Q000175:diagnosis / Q000401:mortality*; D015415:Biomarkers / Q000097:blood; D002986:Clinical Trials as Topic / Q000379:methods*; D015986:Confounding Factors, Epidemiologic; D004341:Drug Evaluation / Q000379:methods; D006801:Humans; D032383:Myocytes, Cardiac / Q000378:metabolism*; D011237:Predictive Value of Tests; D012107:Research Design; D012680:Sensitivity and Specificity; D013514:Surgical Procedures, Operative / Q000009:adverse effects; D019210:Troponin I / Q000097:blood*; D020107:Troponin T / Q000097:blood*
chemical_list: D015415:Biomarkers; D019210:Troponin I; D020107:Troponin T